{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T17:35:33Z","timestamp":1764783333641},"reference-count":31,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,2]],"date-time":"2015-12-02T00:00:00Z","timestamp":1449014400000},"content-version":"vor","delay-in-days":1462,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Thoracic Oncology"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1097\/jto.0b013e31822e71c0","type":"journal-article","created":{"date-parts":[[2011,10,4]],"date-time":"2011-10-04T21:06:56Z","timestamp":1317762416000},"page":"2130-2134","source":"Crossref","is-referenced-by-count":56,"title":["Combination Chemotherapy with Doxorubicin, Vincristine, Cyclophosphamide, and Platinum Compounds for Advanced Thymic Carcinoma"],"prefix":"10.1016","volume":"6","author":[{"given":"Toshihiko","family":"Agatsuma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomonobu","family":"Koizumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shintaro","family":"Kanda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michiko","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhisa","family":"Urushihata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayuki","family":"Hanaoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keishi","family":"Kubo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1097\/JTO.0b013e31822e71c0_bib1","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1097\/00000478-198210000-00003","article-title":"Primary thymic carcinomas","volume":"6","author":"Wick","year":"1982","journal-title":"Am J Surg Pathol"},{"key":"10.1097\/JTO.0b013e31822e71c0_bib2","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1002\/1097-0142(19910215)67:4<1025::AID-CNCR2820670427>3.0.CO;2-F","article-title":"Thymic carcinoma. A clinicopathologic study of 60 cases","volume":"67","author":"Suster","year":"1991","journal-title":"Cancer"},{"key":"10.1097\/JTO.0b013e31822e71c0_bib3","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S0022-5223(94)70112-1","article-title":"Thymic carcinoma. Ten years' experience in twenty patients","volume":"107","author":"Hsu","year":"1994","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1097\/JTO.0b013e31822e71c0_bib4","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0022-5223(98)70273-9","article-title":"Thymic carcinoma: current staging does not predict prognosis","volume":"115","author":"Blumberg","year":"1998","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1097\/JTO.0b013e31822e71c0_bib5","doi-asserted-by":"crossref","first-page":"3115","DOI":"10.1002\/cncr.10588","article-title":"Treatment and prognosis of thymic carcinoma: a retrospective analysis of 40 cases","volume":"94","author":"Ogawa","year":"2002","journal-title":"Cancer"},{"key":"10.1097\/JTO.0b013e31822e71c0_bib6","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.ejcts.2004.03.043","article-title":"Thymic carcinoma. Clinical institutional experience with 15 patients","volume":"26","author":"Takeda","year":"2004","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1097\/JTO.0b013e31822e71c0_bib7","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/JTO.0b013e3181653c71","article-title":"Thymic carcinoma: 30 cases at a single institution","volume":"3","author":"Yano","year":"2008","journal-title":"J Thorac Oncol"},{"key":"10.1097\/JTO.0b013e31822e71c0_bib8","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1002\/1097-0142(19930215)71:4<1219::AID-CNCR2820710408>3.0.CO;2-B","article-title":"Thymic carcinoma. A distinct clinical entity responsive to chemotherapy","volume":"71","author":"Weide","year":"1993","journal-title":"Cancer"},{"key":"10.1097\/JTO.0b013e31822e71c0_bib9","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1093\/jjco\/hyd108","article-title":"Platinum-based chemotherapy with or without thoracic radiation therapy in patients with unresectable thymic carcinoma","volume":"30","author":"Nakamura","year":"2000","journal-title":"Jpn J Clin Oncol"},{"key":"10.1097\/JTO.0b013e31822e71c0_bib10","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1093\/jjco\/hye136","article-title":"Chemotherapy of thymic carcinoma: analysis of seven cases and review of the literature","volume":"31","author":"Kitami","year":"2001","journal-title":"Jpn J Clin Oncol"},{"key":"10.1097\/JTO.0b013e31822e71c0_bib11","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/00000421-200206000-00012","article-title":"Chemotherapy for advanced thymic carcinoma: clinical response to cisplatin, doxorubicin, vincristine, and cyclophosphamide (ADOC chemotherapy)","volume":"25","author":"Koizumi","year":"2002","journal-title":"Am J Clin Oncol"},{"key":"10.1097\/JTO.0b013e31822e71c0_bib12","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1002\/cncr.11606","article-title":"Weekly chemotherapy with cisplatin, vincristine, doxorubicin, and etoposide is an effective treatment for advanced thymic carcinoma","volume":"98","author":"Yoh","year":"2003","journal-title":"Cancer"},{"key":"10.1097\/JTO.0b013e31822e71c0_bib13","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1159\/000097944","article-title":"Persistent and aggressive treatment for thymic carcinoma. Results of a single-institute experience with 25 patients","volume":"70","author":"Maruyama","year":"2006","journal-title":"Oncology"},{"key":"10.1097\/JTO.0b013e31822e71c0_bib14","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.lungcan.2009.03.031","article-title":"Efficacy of chemotherapy with carboplatin and paclitaxel for unresectable thymic carcinoma","volume":"67","author":"Igawa","year":"2010","journal-title":"Lung Cancer"},{"key":"10.1097\/JTO.0b013e31822e71c0_bib15","first-page":"208","article-title":"Intensive chemotherapy with cisplatin, doxorubicin, cyclophosphamide, etoposide and granulocyte colony-stimulating factor for advanced thymoma or thymic cancer: preliminary results","volume":"25","author":"Oshita","year":"1995","journal-title":"Jpn J Clin Oncol"},{"key":"10.1097\/JTO.0b013e31822e71c0_bib16","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1002\/1097-0142(20010601)91:11<2010::AID-CNCR1226>3.0.CO;2-2","article-title":"Combined etoposide, ifosfamide, and cisplatin in the treatment of patients with advanced thymoma and thymic carcinoma: an intergroup trial","volume":"91","author":"Loehrer","year":"2001","journal-title":"Cancer"},{"key":"10.1097\/JTO.0b013e31822e71c0_bib17","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1002\/1097-0142(19910701)68:1<30::AID-CNCR2820680106>3.0.CO;2-4","article-title":"Chemotherapy for invasive thymoma. A 13-year experience","volume":"68","author":"Fornasiero","year":"1991","journal-title":"Cancer"},{"key":"10.1097\/JTO.0b013e31822e71c0_bib18","series-title":"Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart","author":"Travis","year":"2004"},{"key":"10.1097\/JTO.0b013e31822e71c0_bib19","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1002\/1097-0142(19811201)48:11<2485::AID-CNCR2820481123>3.0.CO;2-R","article-title":"Follow-up study of thymomas with special reference to their clinical stages","volume":"48","author":"Masaoka","year":"1981","journal-title":"Cancer"},{"key":"10.1097\/JTO.0b013e31822e71c0_bib20","volume":"Vol. 48","author":"World Health Organization","year":"1979"},{"key":"10.1097\/JTO.0b013e31822e71c0_bib21","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/jnci\/92.3.205","article-title":"New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada","volume":"92","author":"Therasse","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"10.1097\/JTO.0b013e31822e71c0_bib22","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"key":"10.1097\/JTO.0b013e31822e71c0_bib23","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6","article-title":"Reporting results of cancer","volume":"47","author":"Miller","year":"1981","journal-title":"Cancer"},{"key":"10.1097\/JTO.0b013e31822e71c0_bib24","author":"National Cancer Institute"},{"key":"10.1097\/JTO.0b013e31822e71c0_bib25","series-title":"Common Terminology Criteria for Adverse Events (CTCAE) Version 3.0","year":"2003"},{"key":"10.1097\/JTO.0b013e31822e71c0_bib26","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/00000421-198212000-00014","article-title":"Toxicity and response criteria of the Eastern Cooperative Oncology Group","volume":"5","author":"Oken","year":"1982","journal-title":"Am J Clin Oncol"},{"key":"10.1097\/JTO.0b013e31822e71c0_bib27","doi-asserted-by":"crossref","first-page":"S286","DOI":"10.1097\/JTO.0b013e3181f209a8","article-title":"Thymoma: molecular pathology and targeted therapy","volume":"5","author":"Strobel","year":"2010","journal-title":"J Thorac Oncol"},{"key":"10.1097\/JTO.0b013e31822e71c0_bib28","doi-asserted-by":"crossref","first-page":"S361","DOI":"10.1097\/JTO.0b013e3181f21114","article-title":"Targeted therapy for advanced thymic tumors","volume":"5","author":"Rajan","year":"2010","journal-title":"J Thorac Oncol"},{"key":"10.1097\/JTO.0b013e31822e71c0_bib29","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1097\/JTO.0b013e3181a52e25","article-title":"Long lasting response to the multikinase inhibitor bay 43\u20139006 (sorafenib) in a heavily pretreated metastatic thymic carcinoma","volume":"4","author":"Bisagni","year":"2009","journal-title":"J Thorac Oncol"},{"key":"10.1097\/JTO.0b013e31822e71c0_bib30","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s12032-008-9100-0","article-title":"Response to sorafenib in cisplatin-resistant thymic carcinoma: a case report","volume":"26","author":"Li","year":"2009","journal-title":"Med Oncol"},{"key":"10.1097\/JTO.0b013e31822e71c0_bib31","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/sj.bjc.6605740","article-title":"Sunitinib in metastatic thymic carcinomas: laboratory findings and initial clinical experience","volume":"103","author":"Strobel","year":"2010","journal-title":"Br J Cancer"}],"container-title":["Journal of Thoracic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556086415317408?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556086415317408?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,25]],"date-time":"2020-06-25T14:44:00Z","timestamp":1593096240000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1556086415317408"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":31,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["S1556086415317408"],"URL":"https:\/\/doi.org\/10.1097\/jto.0b013e31822e71c0","relation":{},"ISSN":["1556-0864"],"issn-type":[{"value":"1556-0864","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]}}}